Volume 28, Number 6—June 2022
CME ACTIVITY - Synopsis
Cross-Sectional Study of Clinical Predictors of Coccidioidomycosis, Arizona, USA
Table 3
Characteristics | Univariable model |
Multivariable model |
|||
---|---|---|---|---|---|
OR (95% CI) | p value | aOR (95% CI) | p value | ||
Symptoms | |||||
Rash | 19.64 (2.34–164.67) | 0.006 | 9.74 (1.03–92.24) | 0.047 | |
Shortness of breath |
0.43 (0.17–1.09) |
0.075 |
0.36 (0.12–1.07) |
0.066 |
|
Laboratory tests | |||||
Procalcitonin, ng/mL | 0.45 (0.21–0.96) | 0.039 | 0.59 (0.25–1.38) | 0.222 | |
Platelet count, × 103/mm3 | 1.73 (0.98–3.07) | 0.060 | 1.70 (0.90–3.22) | 0.100 | |
Eosinophil count, × 103/µL | 2.18 (1.19–4.01) | 0.012 | 1.62 (0.79–3.32) | 0.186 |
*Participants were recruited from among patients in emergency departments and affiliated clinics, including 35 coccidioidomycosis-positive and 64 coccidioidomycosis-negative participants. Bold text indicates statistical significance. aOR, adjusted OR; OR, odds ratio.
Page created: March 21, 2022
Page updated: May 20, 2022
Page reviewed: May 20, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.